Get the Stockscreener App
45.75
1.33%
0.5333
Soleno Therapeutics Inc stock is traded at $45.75, with a volume of 1.18M.
It is up +1.33% in the last 24 hours and down -10.80% over the past month.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
See More
Previous Close:
$45.22
Open:
$45
24h Volume:
1.18M
Relative Volume:
0.70
Market Cap:
$2.46B
Revenue:
-
Net Income/Loss:
$-38.99M
P/E Ratio:
-15.27
EPS:
-2.9966
Net Cash Flow:
$-24.94M
1W Performance:
-1.02%
1M Performance:
-10.80%
6M Performance:
-47.12%
1Y Performance:
-0.17%
1-Day Range:
$44.69
$46.99
1-Week Range:
$44.69
$47.98
52-Week Range:
$41.50
$90.32
Soleno Therapeutics Inc Stock (SLNO) Company Profile
Name
Soleno Therapeutics Inc
Sector
Industry
Phone
650-213-8444
Address
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
Compare SLNO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SLNO
Soleno Therapeutics Inc
|
45.76 | 2.43B | 0 | -38.99M | -24.94M | -2.9966 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.92 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
773.55 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
405.75 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
801.69 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.75 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-18-25 | Initiated | Wolfe Research | Outperform |
| Oct-07-25 | Initiated | Goldman | Buy |
| Aug-20-25 | Initiated | Wells Fargo | Overweight |
| Jun-23-25 | Initiated | TD Cowen | Buy |
| Mar-05-25 | Resumed | Stifel | Buy |
| Dec-02-24 | Reiterated | Robert W. Baird | Outperform |
| Dec-02-24 | Reiterated | Stifel | Buy |
| Sep-03-24 | Initiated | H.C. Wainwright | Buy |
| May-10-24 | Initiated | Robert W. Baird | Outperform |
| Feb-05-24 | Initiated | Piper Sandler | Overweight |
| Jan-23-24 | Initiated | Stifel | Buy |
| Nov-21-23 | Resumed | Guggenheim | Buy |
| Sep-29-20 | Initiated | Guggenheim | Buy |
| Jan-10-20 | Initiated | Craig Hallum | Buy |
| Dec-23-19 | Initiated | Oppenheimer | Outperform |
| Feb-13-18 | Reiterated | Maxim Group | Buy |
View All
Soleno Therapeutics Inc Stock (SLNO) Latest News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno ... - Bluefield Daily Telegraph
Do You Believe in the Growth Prospects of Soleno Therapeutics (SLNO)? - Insider Monkey
Soleno’s PWS treatment study results published in endocrinology journal By Investing.com - Investing.com India
Soleno Therapeutics Announces Publication of Positive Study Results for VYKAT XR in Journal of Clinical Endocrinology and Metabolism - Quiver Quantitative
New PWS hunger drug shows symptoms worsen off treatment in key study - Stock Titan
Soleno Therapeutics, Inc. $SLNO Stake Cut by Voya Investment Management LLC - MarketBeat
SLNO News Today | Why did Soleno Therapeutics stock go up today? - MarketBeat
Understanding Momentum Shifts in (SLNO) - Stock Traders Daily
Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Risk Hedge: Why analysts recommend Soleno Therapeutics Inc 6XC stock2025 Trading Volume Trends & Community Consensus Trade Alerts - moha.gov.vn
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Soleno Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (SLNO) - Business Wire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Soleno Therapeutics, Inc. (SLNO) And Encourages Shareholders to Connect - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc.SLNO - FinancialContent
Soleno Therapeutics stock slides today: SLNO drops on investor-alert headline as biotech sector slips - ts2.tech
2025-12-29 | Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Stockholders to Inquire about Securities Investigation | NDAQ:SLNO | Press Release - Stockhouse
Soleno Therapeutics, Inc. $SLNO Stake Lessened by Harbor Capital Advisors Inc. - MarketBeat
Market Sentiment Around Loss-Making Soleno Therapeutics, Inc. (NASDAQ:SLNO) - 富途牛牛
Soleno Therapeutics Shares Dip Following $200 Million Stock Offering Pricing - MSN
Piper Sandler Reaffirms Overweight Rating on Soleno (SLNO) Driven by Strong VYKAT XR Prospects - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
2025-12-28 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Investors to Learn More About the Investigation | NDAQ:SLNO | Press Release - Stockhouse
Soleno Therapeutics Earnings Notes - Trefis
Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Is Soleno Therapeutics Inc. stock affected by interest rate hikesMarket Sentiment Report & Free High Margin Investment Plays - bollywoodhelpline.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Soleno Therapeutics, Inc. (SLNO) And Encourages Investors to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
2025-12-24 | Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Stockholders to Inquire about Securities Investigation | NDAQ:SLNO | Press Release - Stockhouse
Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Soleno Therapeutics (NASDAQ:SLNO) Share Price Crosses Below 50-Day Moving AverageWhat's Next? - MarketBeat
Soleno Therapeutics Inc (NASDAQ:SLNO) Nasdaq today Biopharma Niche Growth - Kalkine Media
Precision Trading with Soleno Therapeutics Inc. (SLNO) Risk Zones - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Investors to Inquire about Securities Investigation - ACCESS Newswire
Is Soleno Therapeutics (NASDAQ:SLNO) Using Debt Sensibly? - 富途牛牛
Fed Meeting: What momentum indicators show for Soleno Therapeutics Inc. stock2025 Market WrapUp & Weekly Return Optimization Alerts - Улправда
Will Soleno Therapeutics Inc. stock see insider buyingQuarterly Portfolio Report & Accurate Entry/Exit Alerts - Улправда
Why Soleno Therapeutics Inc. stock could rally in 2025Dollar Strength & Weekly Top Stock Performers List - Улправда
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Soleno Therapeutics, Inc. (SLNO) And Encourages Investors to Reach Out - ACCESS Newswire
Can Soleno Therapeutics Inc. stock hit record highs again2025 Year in Review & Fast Gaining Stock Reports - DonanımHaber
How Soleno Therapeutics Inc. stock performs in weak economyPortfolio Risk Report & Low Drawdown Momentum Trade Ideas - Улправда
Rate Hike: What momentum indicators show for Soleno Therapeutics Inc. stockJuly 2025 Technicals & Community Verified Trade Signals - ulpravda.ru
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Soleno Therapeutics, Inc. (SLNO) And Encourages Stockholders to Reach Out - ACCESS Newswire
VP Huang Surrenders 812 Of Soleno Therapeutics Inc [SLNO] - TradingView — Track All Markets
VP Yen Surrenders 904 Of Soleno Therapeutics Inc [SLNO] - TradingView — Track All Markets
CFO Mackaness Surrenders 2,013 Of Soleno Therapeutics Inc [SLNO] - TradingView — Track All Markets
Soleno Therapeutics (SLNO) CEO discloses 100,000-share gift and updated holdings - Stock Titan
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeu - GuruFocus
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses - Morningstar
Reassessing Soleno Therapeutics (SLNO) Valuation After Wolfe Research’s Confidence Boost and Improving Fundamentals - Sahm
Soleno Therapeutics (SLNO) Valuation Check After Wolfe Research’s Optimistic New Coverage and Stock Pop - Yahoo Finance
Soleno Therapeutics Inc Stock (SLNO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Soleno Therapeutics Inc Stock (SLNO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hirano Patricia C | SEE REMARKS |
Jul 01 '25 |
Sale |
82.76 |
3,830 |
316,971 |
13,206 |
2.45%
0.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):